{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:57:49Z","timestamp":1775152669735,"version":"3.50.1"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The prevalence of transmitted human immunodeficiency virus type 1 drug resistance in Angola in 2001 in 196 untreated patients was investigated. All subtypes were detected, along with unclassifiable and complex recombinant strains. Numerous new polymorphisms were identified in the reverse transcriptase and protease. Two (1.6%) unrelated patients harbored nucleoside reverse transcriptase inhibitor- and nonnucleoside reverse transcriptase inhibitor-resistant viruses (mutations: M41L, D67N, M184V, L210W, T215Y or T215F, and K103N). Continued surveillance of drug resistance is required for maximization of ART efficacy in Angola.<\/jats:p>","DOI":"10.1128\/aac.00110-09","type":"journal-article","created":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:45:41Z","timestamp":1242089141000},"page":"3156-3158","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":11,"title":["Antiretroviral Drug Resistance Surveillance among Treatment-Naive Human Immunodeficiency Virus Type 1-Infected Individuals in Angola: Evidence for Low Level of Transmitted Drug Resistance"],"prefix":"10.1128","volume":"53","author":[{"given":"Ine\u0302s","family":"Ba\u0301rtolo","sequence":"first","affiliation":[{"name":"Unidade dos Retrovi\u0301rus e Infecc\u0327o\u0303es Associadas, Centro de Patoge\u0301nese Molecular, Faculdade de Farma\u0301cia da Universidade de Lisboa, Lisboa, Portugal"}]},{"given":"Cheila","family":"Rocha","sequence":"additional","affiliation":[{"name":"Unidade dos Retrovi\u0301rus e Infecc\u0327o\u0303es Associadas, Centro de Patoge\u0301nese Molecular, Faculdade de Farma\u0301cia da Universidade de Lisboa, Lisboa, Portugal"}]},{"given":"Jose\u0301","family":"Bartolomeu","sequence":"additional","affiliation":[{"name":"Servic\u0327o Nacional de Sangue, Luanda, Angola"}]},{"given":"Anto\u0301nio","family":"Gama","sequence":"additional","affiliation":[{"name":"Malongo, Medical Department, Cabinda, Angola"}]},{"given":"Marlene","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Hospital Militar Principal, Luanda, Angola"}]},{"given":"Ana","family":"Mendes","sequence":"additional","affiliation":[{"name":"Hospital Militar Principal, Luanda, Angola"}]},{"given":"Filipa","family":"Cristina","sequence":"additional","affiliation":[{"name":"Abbott Molecular, Amadora, Portugal"}]},{"given":"Sven","family":"Thamm","sequence":"additional","affiliation":[{"name":"Abbott GmbH &amp; Co. KG, Wiesbaden, Germany"}]},{"given":"Marta","family":"Epalanga","sequence":"additional","affiliation":[{"name":"Servic\u0327o Nacional de Sangue, Luanda, Angola"}]},{"given":"Patri\u0301cia Cavaco","family":"Silva","sequence":"additional","affiliation":[{"name":"Unidade dos Retrovi\u0301rus e Infecc\u0327o\u0303es Associadas, Centro de Patoge\u0301nese Molecular, Faculdade de Farma\u0301cia da Universidade de Lisboa, Lisboa, Portugal"},{"name":"Instituto Superior de Cie\u0302ncias da Sau\u0301de Egas Moniz, Monte de Caparica, Portugal"}]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[{"name":"Unidade dos Retrovi\u0301rus e Infecc\u0327o\u0303es Associadas, Centro de Patoge\u0301nese Molecular, Faculdade de Farma\u0301cia da Universidade de Lisboa, Lisboa, Portugal"},{"name":"Instituto Superior de Cie\u0302ncias da Sau\u0301de Egas Moniz, Monte de Caparica, Portugal"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/135965350801302S01","volume":"13","year":"2008","unstructured":"Abegaz, W. E., Z. Grossman, D. Wolday, D. Ram, J. Kaplan, K. Sibide, T. Wuhib, S. Ismael, J. Nkengasong, T. Mekonen, H. Berhanu, T. Messele, S. Lulseged, S. Maayan, and Y. Mengistu. 2008. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Antivir. Ther.13(Suppl. 2):89-94.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/aid.2005.21.306","volume":"21","year":"2005","unstructured":"Bartolo, I., M. Epalanga, J. Bartolomeu, M. Fonseca, A. Mendes, A. Gama, and N. Taveira. 2005. High genetic diversity of human immunodeficiency virus type 1 in Angola. AIDS Res. Hum Retrovir.21:306-310.","journal-title":"AIDS Res. Hum Retrovir."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2008.05.003"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00712-06"},{"key":"e_1_3_2_6_2","first-page":"1","volume":"13","year":"2008","unstructured":"Bennett, D. E., S. Bertagnolio, D. Sutherland, and C. F. Gilks. 2008. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther.13(Suppl. 2):1-13.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","volume":"13","year":"2008","unstructured":"Bennett, D. E., M. Myatt, S. Bertagnolio, D. Sutherland, and C. F. Gilks. 2008. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther.13(Suppl. 2):25-36.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2007.0173"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/jac\/dkm515","volume":"61","year":"2008","unstructured":"Garrido, C., N. Zahonero, D. Fernandes, D. Serrano, A. R. Silva, N. Ferraria, F. Antunes, J. Gonzalez-Lahoz, V. Soriano, and C. de Mendoza. 2008. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J. Antimicrob. Chemother.61:694-698.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328013caff"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69158-7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31803260df"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350801302S02","volume":"13","year":"2008","unstructured":"Kamoto, K., and J. Aberle-Grasse. 2008. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi. Antivir. Ther.13(Suppl. 2):83-87.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21139"},{"key":"e_1_3_2_15_2","first-page":"4","volume":"6","year":"2004","unstructured":"Nkengasong, J. N., C. Adje-Toure, and P. J. Weidle. 2004. HIV antiretroviral drug resistance in Africa. AIDS Rev.6:4-12.","journal-title":"AIDS Rev."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135965350801302S09","volume":"13","year":"2008","unstructured":"Pillay, V., J. Ledwaba, G. Hunt, M. Rakgotho, B. Singh, L. Makubalo, D. E. Bennett, A. Puren, and L. Morris. 2008. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir. Ther.13(Suppl. 2):101-107.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm276"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/135965350801302S13","volume":"13","year":"2008","unstructured":"Shafer, R. W., S. Y. Rhee, and D. E. Bennett. 2008. Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir. Ther.13(Suppl. 2):59-68.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328011e691"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000219290.49152.6a"},{"key":"e_1_3_2_21_2","first-page":"77","volume":"13","year":"2008","unstructured":"Somi, G. R., T. Kibuka, K. Diallo, T. Tuhuma, D. E. Bennett, C. Yang, C. Kagoma, E. F. Lyamuya, R. O. Swai, and S. Kassim. 2008. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir. Ther.13(Suppl. 2):77-82.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_22_2","unstructured":"Angola. 2008"},{"key":"e_1_3_2_23_2","first-page":"17","year":"2007","unstructured":"van de Vijver, D., A. Wensing, and C. Boucher. 2007. The epidemiology of transmission of drug resistant HIV-1, p. 17-36. In T. Leitner, B. Foley, B. Hahn, P. Marx, F. McCutchan, J. Mellors, S. Wolinsky, and B. Korber (ed.), HIV sequence compendium 2006\/2007. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.","journal-title":"HIV sequence compendium 2006\/2007."},{"key":"e_1_3_2_24_2","unstructured":"Angola: HIV\/AIDS treatment. 2005"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00110-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00110-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:56:08Z","timestamp":1684983368000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00110-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1128\/AAC.00110-09"],"URL":"https:\/\/doi.org\/10.1128\/aac.00110-09","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"2009-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}